Skip to main content
Equibles

BARCLAYS PLC

Position in CRMD — CorMedix Inc.

CIK 312069 LONDON, X0
Back to CRMD Full portfolio

Position in CRMD

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$343,507
+$89,331 QoQ
Shares Held
43,759
+16.9% QoQ
Ownership
0.056%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#80
of 194 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CRMD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,600 across 455 Biotechnology names. CRMD ranks #194 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 733,274 $364,239,192
2 REGN
Regeneron Pharmaceuticals, Inc.
 256,192 $159,745,957
3 IONS
Ionis Pharmaceuticals Inc
 1,603,136 $127,112,653
4 ARGX
Argenx SE
 134,427 $124,717,337
5 MRNA
Moderna, Inc.
 1,035,126 $72,489,872
6 BBIO
BridgeBio Pharma, Inc.
 714,423 $53,210,224
7 TGTX
Tg Therapeutics, Inc.
 957,848 $52,624,168
8 DNTH
Dianthus Therapeutics, Inc. /DE/
 431,753 $42,087,281

All Filings in CRMD

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $343,507 43,759
2026-03-31 $254,176 37,434
2025-12-31 $1,604,125 137,930
2025-09-30 $1,518,075 130,531
2025-06-30 $1,792,866 145,525
2025-03-31 $540,792 87,791
2024-12-31 $855,376 105,602
2024-09-30 $629,189 77,870
2024-06-30 $701,425 161,992
2024-03-31 $770,611 181,748
2023-12-31 $822,108 218,646
2023-09-30 $563,613 152,328
2023-06-30 $603,622 152,046
2023-03-31 $676,985 163,523
2022-12-31 $604,017 143,132
2022-09-30 $405,063 143,132
2022-06-30 $3,015,000 750,000
2022-03-31 $33,723 6,154
2021-12-31 $209,281 45,996
2021-09-30 $72,014 15,487
2021-06-30 $131,540 19,175
2021-03-31 $271,957 27,223
2020-12-31 $76,120 10,245
2020-09-30 $83,865 13,908
2020-06-30 $89,352 14,183
2020-03-31 $30,392 8,466